Alliance A021806: A phase III trial evaluating perioperative versus adjuvant therapy for resectable pancreatic cancer.

被引：0
|
作者：
Chawla, Akhil
Shi, Qian
Ko, Andrew H.
Beg, Shaalan
Varghese, Anna M.
Behrman, Stephen W.
Bloomston, Mark
Ahmed, Firas Salem
Frankel, Wendy L.
Dixon, Jesse G.
Carrero, Xiomara W.
Shergill, Ardaman
Crawley, Jamie
Akin, Oguz
Renouf, Daniel John
Zogopoulos, George
Hubbard, Joleen M.
Meyerhardt, Jeffrey A.
O'Reilly, Eileen Mary
Ferrone, Cristina R.
机构：
[1] Northwestern Univ, Robert H Lurie Comprehens Canc, Chicago, IL USA
[2] Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA
[3] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[4] UT Southwestern Simmons Canc Ctr, Dallas, TX USA
[5] Mem Sloan Kettering Canc Ctr, New York, NY USA
[6] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[7] South Florida Surg Oncol, Ft Myers, FL USA
[8] Columbia Univ, Med Ctr, New York, NY USA
[9] Ohio State Univ, Arthur G James Canc Hosp, Comprehens Canc Ctr, Columbus, OH USA
[10] Univ Chicago, Sect Hematol & Oncol, Dept Med, Med Ctr, Chicago, IL USA
[11] Univ Chicago, Chicago, IL USA
[12] Univ British Columbia, BC Canc Agcy, Vancouver, BC, Canada
[13] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[14] Mayo Clin, Dept Med Oncol, Rochester, MN USA
[15] Alliance Clin Trials Oncol, Chicago, IL USA
[16] Massachusetts Gen Hosp, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4204
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ALLIANCE A021806: A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
    Eade, Alyssa V.
    Friedman, Lindsay R.
    Larrain, Carolina
    Rainey, Ashley
    Hernandez, Jonathan M.
    Chawla, Akhil
    Ferrone, Cristina R.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (10) : 6373 - 6374
  • [2] Perioperative versus adjuvant therapy in resectable pancreas cancer.
    Wang, Tianyi
    Mills, Jamie N.
    Ellsworth, Brandon
    Griffith, Brian
    Gunchick, Valerie
    Enzler, Thomas
    Crysler, Oxana V.
    Cuneo, Kyle
    Nathan, Hari
    Lawrence, Theodore Steven
    Zalupski, Mark
    Cho, Clifford
    Sahai, Vaibhav
    Bednar, Filip
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 703 - 703
  • [3] Adjuvant Therapy versus neoadjuvant Therapy for Borderline resectable Pancreatic Cancer
    Manekeller, Steffen
    ZENTRALBLATT FUR CHIRURGIE, 2018, 143 (05): : 457 - 457
  • [4] Randomized multicenter phase II/III study with adjuvant gemcitabine versus neoadjuvant/adjuvant FOLFIRINOX in resectable pancreatic cancer: The NEPAFOX trial.
    Hozaeel, Wael
    Pauligk, Claudia
    Homann, Nils
    Luley, Kim
    Kraus, Thomas Werner
    Trojan, Jorg
    Bechstein, Wolf O.
    Grimm, Kersten
    Heise, Bettina
    Schmiegel, Wolff
    Pink, Daniel
    Al-Batran, Salah-Eddin
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Randomized multicenter phase II/III study with adjuvant gemcitabine versus neoadjuvant/adjuvant FOLFIRINOX in resectable pancreatic cancer: The NEPAFOX trial.
    Al-Batran, Salah-Eddin
    Reichart, Alexander
    Bankstahl, Ulli Simone
    Pauligk, Claudia
    Kraus, Thomas Werner
    Bechstein, Wolf Otto
    Trojan, Jorg
    Behrend, Matthias
    Potenberg, Jochem
    Homann, Nils
    Venerito, Marino
    Bohle, Wolfram
    Varvenne, Michael
    Bolling, Claus
    Behringer, Dirk M.
    Kratz-Alber, Karsten
    Siegler, Gabriele Margareta
    Hozaeel, Wael
    Goetze, Thorsten Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [6] Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial
    Goetze, Thorsten O.
    Reichart, Alexander
    Bankstahl, Ulli S.
    Pauligk, Claudia
    Loose, Maria
    Kraus, Thomas W.
    Elshafei, Moustafa
    Bechstein, Wolf O.
    Trojan, Joerg
    Behrend, Matthias
    Homann, Nils
    Venerito, Marino
    Bohle, Wolfram
    Varvenne, Michael
    Bolling, Claus
    Behringer, Dirk M.
    Kratz-Albers, Karsten
    Siegler, Gabriele M.
    Hozaeel, Wael
    Al-Batran, Salah-Eddin
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (06) : 4073 - 4083
  • [7] Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial
    Thorsten O. Goetze
    Alexander Reichart
    Ulli S. Bankstahl
    Claudia Pauligk
    Maria Loose
    Thomas W. Kraus
    Moustafa Elshafei
    Wolf O. Bechstein
    Jörg Trojan
    Matthias Behrend
    Nils Homann
    Marino Venerito
    Wolfram Bohle
    Michael Varvenne
    Claus Bolling
    Dirk M. Behringer
    Karsten Kratz-Albers
    Gabriele M. Siegler
    Wael Hozaeel
    Salah-Eddin Al-Batran
    Annals of Surgical Oncology, 2024, 31 : 4073 - 4083
  • [8] Carbon Ion Radiotherapy Versus Perioperative Adjuvant Chemotherapy and Curative Surgery for Resectable Pancreatic Cancer
    Yamamoto, Naoto
    Oshima, Takashi
    Kawahara, Shinnosuke
    Takahashi, Daishi
    Kamioka, Yuto
    Murakawa, Masaaki
    Katoh, Hiroyuki
    Ueno, Makoto
    Morinaga, Soichiro
    ANTICANCER RESEARCH, 2023, 43 (02) : 809 - 815
  • [9] Factors affecting the outcome of adjuvant therapy in stage III pancreatic cancer.
    Krishnan, Mridula
    Chintalacheruvu, Lakshmi Manogna
    George, Nicholas B.
    Silva, Carlos J.
    Khanal, Nabin
    Walters, Ryan W.
    Silberstein, Peter T.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Phase I/II trial of perioperative avelumab in combination with chemoradiation in the treatment of stage II/III resectable esophageal cancer.
    Uboha, Nataliya Volodymyrivna
    Maloney, James D.
    McCarthy, Daniel
    Deming, Dustin A.
    LoConte, Noelle K.
    Matkowskyj, Kristina
    Eickhoff, Jens C.
    Mulkerin, Daniel
    DeCamp, Malcolm M.
    Lubner, Sam Joseph
    Turk, Anita Ahmed
    Bassetti, Michael Frederick
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
12345